According to Our company market research, the sales value of mecapegfilgrastim has grown significantly since its launch in China in 2018, reaching approximately CNY432 million (USD66.5 million) in 202
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |